Cargando…

Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer's disease

The voxel-based morphometry (VBM) technique using brain magnetic resonance imaging (MRI) objectively maps gray matter loss on a voxel-by-voxel basis after anatomic standardization. In patients with Alzheimer's disease (AD), reductions of gray matter volume, mainly in the medial temporal structu...

Descripción completa

Detalles Bibliográficos
Autores principales: Imabayashi, Etsuko, Matsuda, Hiroshi, Tabira, Takeshi, Arima, Kunimasa, Araki, Nobuo, Ishii, Kenji, Yamashita, Fumio, Iwatsubo, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Inc 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869687/
https://www.ncbi.nlm.nih.gov/pubmed/24381817
http://dx.doi.org/10.1002/brb3.146
_version_ 1782296593531142144
author Imabayashi, Etsuko
Matsuda, Hiroshi
Tabira, Takeshi
Arima, Kunimasa
Araki, Nobuo
Ishii, Kenji
Yamashita, Fumio
Iwatsubo, Takeshi
author_facet Imabayashi, Etsuko
Matsuda, Hiroshi
Tabira, Takeshi
Arima, Kunimasa
Araki, Nobuo
Ishii, Kenji
Yamashita, Fumio
Iwatsubo, Takeshi
author_sort Imabayashi, Etsuko
collection PubMed
description The voxel-based morphometry (VBM) technique using brain magnetic resonance imaging (MRI) objectively maps gray matter loss on a voxel-by-voxel basis after anatomic standardization. In patients with Alzheimer's disease (AD), reductions of gray matter volume, mainly in the medial temporal structures, have been reported; however, inhomogeneity and geometric distortion of the field intensity hampers the reproducibility of MRI. In the present study, we developed a novel computed tomography (CT)-based VBM method and used this technique to detect volume loss in AD patients as compared with normal controls. The results were compared with MRI-based VBM using the same subjects. Pittsburgh Compound B ((11)C-PIB) positron emission tomography (PET)/CT was performed and two experts in neuro-nuclear medicine judged whether regional amyloid β load was consistent with a diagnosis of AD. Before the injection of (11)C-PIB, high-quality CT scans were obtained using the same PET/CT equipment. MRI was performed within a mean interval of 25.1 ± 8.2 days before the PET/CT scan. Using statistical parametric mapping 8 (SPM8), the extracted gray matter images from CT and MRI were spatially normalized using a gray matter template and smoothed using a Gaussian kernel. Group comparisons were performed using SPM8 between five (11)C-PIB-positive patients with probable AD and seven (11)C-PIB-negative age-matched controls with normal cognition. Gray matter volumes in the bilateral medial temporal areas were reduced in the AD group as compared with the cognitively normal group in both CT-based VBM (in the left; P < 0.0001, cluster size 2776 and in the right; P < 0.0001, cluster size 630) and MRI-based VBM (in the left; P < 0.0001, cluster size 381 and in the right, P < 0.0001, cluster size 421). This newly developed CT-based VBM technique can detect significant atrophy in the entorhinal cortex in probable AD patients as previously reported using MRI-based VBM. However, CT-VBM was more sensitive and revealed larger areas of significant atrophy than MR-VBM.
format Online
Article
Text
id pubmed-3869687
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Blackwell Publishing Inc
record_format MEDLINE/PubMed
spelling pubmed-38696872013-12-31 Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer's disease Imabayashi, Etsuko Matsuda, Hiroshi Tabira, Takeshi Arima, Kunimasa Araki, Nobuo Ishii, Kenji Yamashita, Fumio Iwatsubo, Takeshi Brain Behav Original Research The voxel-based morphometry (VBM) technique using brain magnetic resonance imaging (MRI) objectively maps gray matter loss on a voxel-by-voxel basis after anatomic standardization. In patients with Alzheimer's disease (AD), reductions of gray matter volume, mainly in the medial temporal structures, have been reported; however, inhomogeneity and geometric distortion of the field intensity hampers the reproducibility of MRI. In the present study, we developed a novel computed tomography (CT)-based VBM method and used this technique to detect volume loss in AD patients as compared with normal controls. The results were compared with MRI-based VBM using the same subjects. Pittsburgh Compound B ((11)C-PIB) positron emission tomography (PET)/CT was performed and two experts in neuro-nuclear medicine judged whether regional amyloid β load was consistent with a diagnosis of AD. Before the injection of (11)C-PIB, high-quality CT scans were obtained using the same PET/CT equipment. MRI was performed within a mean interval of 25.1 ± 8.2 days before the PET/CT scan. Using statistical parametric mapping 8 (SPM8), the extracted gray matter images from CT and MRI were spatially normalized using a gray matter template and smoothed using a Gaussian kernel. Group comparisons were performed using SPM8 between five (11)C-PIB-positive patients with probable AD and seven (11)C-PIB-negative age-matched controls with normal cognition. Gray matter volumes in the bilateral medial temporal areas were reduced in the AD group as compared with the cognitively normal group in both CT-based VBM (in the left; P < 0.0001, cluster size 2776 and in the right; P < 0.0001, cluster size 630) and MRI-based VBM (in the left; P < 0.0001, cluster size 381 and in the right, P < 0.0001, cluster size 421). This newly developed CT-based VBM technique can detect significant atrophy in the entorhinal cortex in probable AD patients as previously reported using MRI-based VBM. However, CT-VBM was more sensitive and revealed larger areas of significant atrophy than MR-VBM. Blackwell Publishing Inc 2013-07 2013-06-30 /pmc/articles/PMC3869687/ /pubmed/24381817 http://dx.doi.org/10.1002/brb3.146 Text en © 2013 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Original Research
Imabayashi, Etsuko
Matsuda, Hiroshi
Tabira, Takeshi
Arima, Kunimasa
Araki, Nobuo
Ishii, Kenji
Yamashita, Fumio
Iwatsubo, Takeshi
Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer's disease
title Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer's disease
title_full Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer's disease
title_fullStr Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer's disease
title_full_unstemmed Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer's disease
title_short Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer's disease
title_sort comparison between brain ct and mri for voxel-based morphometry of alzheimer's disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869687/
https://www.ncbi.nlm.nih.gov/pubmed/24381817
http://dx.doi.org/10.1002/brb3.146
work_keys_str_mv AT imabayashietsuko comparisonbetweenbrainctandmriforvoxelbasedmorphometryofalzheimersdisease
AT matsudahiroshi comparisonbetweenbrainctandmriforvoxelbasedmorphometryofalzheimersdisease
AT tabiratakeshi comparisonbetweenbrainctandmriforvoxelbasedmorphometryofalzheimersdisease
AT arimakunimasa comparisonbetweenbrainctandmriforvoxelbasedmorphometryofalzheimersdisease
AT arakinobuo comparisonbetweenbrainctandmriforvoxelbasedmorphometryofalzheimersdisease
AT ishiikenji comparisonbetweenbrainctandmriforvoxelbasedmorphometryofalzheimersdisease
AT yamashitafumio comparisonbetweenbrainctandmriforvoxelbasedmorphometryofalzheimersdisease
AT iwatsubotakeshi comparisonbetweenbrainctandmriforvoxelbasedmorphometryofalzheimersdisease
AT comparisonbetweenbrainctandmriforvoxelbasedmorphometryofalzheimersdisease